- Home
- CELC vs MERC Comparison
CELC vs MERC Comparison
Compare CELC & MERC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- MERC
- Stock Information
- Founded
- CELC 2011
- MERC 1968
- Country
- CELC United States
- MERC Canada
- Employees
- CELC N/A
- MERC N/A
- Industry
- CELC Medical Specialities
- MERC Paper
- Sector
- CELC Health Care
- MERC Basic Materials
- Exchange
- CELC Nasdaq
- MERC Nasdaq
- Market Cap
- CELC 391.0M
- MERC 468.8M
- IPO Year
- CELC 2017
- MERC 1987
- Fundamental
- Price
- CELC $10.11
- MERC $6.15
- Analyst Decision
- CELC Strong Buy
- MERC Hold
- Analyst Count
- CELC 6
- MERC 2
- Target Price
- CELC $30.17
- MERC $7.75
- AVG Volume (30 Days)
- CELC 248.4K
- MERC 338.0K
- Earning Date
- CELC 03-31-2025
- MERC 05-08-2025
- Dividend Yield
- CELC N/A
- MERC 4.87%
- EPS Growth
- CELC N/A
- MERC N/A
- EPS
- CELC N/A
- MERC N/A
- Revenue
- CELC N/A
- MERC $2,043,360,000.00
- Revenue This Year
- CELC $49.98
- MERC $3.26
- Revenue Next Year
- CELC N/A
- MERC $5.78
- P/E Ratio
- CELC N/A
- MERC N/A
- Revenue Growth
- CELC N/A
- MERC 2.48
- 52 Week Low
- CELC $8.53
- MERC $5.33
- 52 Week High
- CELC $22.04
- MERC $11.20
- Technical
- Relative Strength Index (RSI)
- CELC 43.41
- MERC 38.81
- Support Level
- CELC $9.98
- MERC $6.45
- Resistance Level
- CELC $10.70
- MERC $6.78
- Average True Range (ATR)
- CELC 0.68
- MERC 0.24
- MACD
- CELC 0.06
- MERC -0.05
- Stochastic Oscillator
- CELC 28.38
- MERC 27.17
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About MERC Mercer International Inc.
Mercer International Inc is a forest products company with two reportable operating segments in pulp and solid wood. The pulp segment consists of the manufacture, sale, and distribution of pulp, electricity, and chemicals. The company has a geographical presence in the USA, Germany, China, and Other countries, where the majority of revenue is generated from the USA. The majority of the revenue is generated from the Pulp segment.